Antifungal Prophylaxis and Pre-Emptive Therapy
- 1 November 2009
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 69 (Supplement) , 75-78
Abstract
In recent years, several reports have underlined the increasing role of fungal infections as a cause of morbidity and mortality in hospitalized non-haematological patients. For this reason, and also in light of the high mortality rate associated with these infections, chemoprophylaxis has been advocated for surgical patients hospitalized in intensive care units (ICUs). The available evidence suggests that the triazoles fluconazole and itraconazole are able to decrease Candida colonization and possibly infection compared with placebo, but this result has only been obtained in high-risk patients undergoing repeated surgical procedures for tertiary peritonitis. Consequently, triazole antifungal prophylaxis should be used with caution, and only in patients at high risk of invasive candidiasis, including high-risk surgical and ICU patients. A pre-emptive approach, defined as initiating antifungal treatment without confirmation of fungal infection, seems to be effective and safe.Keywords
This publication has 27 references indexed in Scilit:
- A Multicenter, Randomized Trial of Prophylactic Fluconazole in Preterm NeonatesNew England Journal of Medicine, 2007
- A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*Critical Care Medicine, 2006
- Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis*Critical Care Medicine, 2005
- Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients(*)Critical Care Medicine, 2004
- TRENDS IN INVASIVE FUNGAL INFECTIONS IN LIVER TRANSPLANT RECIPIENTSTransplantation, 2002
- Risk factors for candidemia in Neonatal Intensive Care Unit patientsThe Pediatric Infectious Disease Journal, 2000
- Bloodstream Infections Due to Candida Species: SENTRY Antimicrobial Surveillance Program in North America and Latin America, 1997-1998Antimicrobial Agents and Chemotherapy, 2000
- Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clinical Infectious Diseases, 1999
- Candida Colonization and Subsequent Infections in Critically III Surgical PatientsAnnals of Surgery, 1994
- CLINICAL SIGNIFICANCE OF CANDIDA ISOLATED FROM PERITONEUM IN SURGICAL PATIENTSThe Lancet, 1989